Department of Health and Human Services (HHS) agencies—including the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Administration for Strategic…
Learn MoreWhen nations implement pharmaceutical price controls, they reduce pharmaceutical revenues, which then reduces investments in further R&D, limiting future generations’ access to new novel treatments needed to fight diseases such…
Learn MoreGovernors have prioritized addressing healthcare workforce shortages related to retirement and burnout from the COVID-19 pandemic, the “silver wave” of baby boom generation workers aging out of the workforce and…
Learn MoreIn 2022, the WHO Science Division initiated a horizon scan to identify innovations in science and technology that could improve global health, including to address health needs that are frequently…
Learn MoreThere is an increasing appetite to apply artificial intelligence (AI) to solve many of medicine’s pressing problems, including earlier cancer detection, drug discovery, prevention, genomics, and relieving the workload of…
Learn MoreGovWhitePapers published its latest trend report on the lasting benefits of telehealth post-pandemic. This publication discusses four top trends, including equitable access to care, empowering of patients, support needed for…
Learn More